Current use and limitations of direct thrombin inhibitors in pediatric ECMO: A European survey

Philippe Gardeton, Nicolas Drillaud, Ariane Willems, Nicolas Joram, Alexis Chenouard, Matteo Di Nardo, Chiara Giorni, Nina Buchtele, Pierre Bourgoin, Pediatric Intensive Care Unit, Nantes University Hospital, Hemophilia Treatment Center, Nantes University Hospital, Pediatric Intensive Care Unit, s Hospital , of Brussel, Pediatric Intensive Care Unit, s Hospital Bambino Gesù, Pediatric Cardiac Intensive Care Unit, s Hospital Bambino Gesù, Department of Medicine I, Intensive Care Unit , Medical University of Vienna

Perfusion

Published online on April 21, 2026

Abstract

Perfusion, Volume 41, Issue 5, Page 650-657, July 2026.
IntroductionDirect thrombin inhibitors (DTIs) are an alternative to unfractionated heparin during pediatric ECMO. We aimed to describe their use and limitations across Europe.MethodsFifty-two pediatric EuroELSO centers were surveyed from July to December ...